Hector Francisco Valdovinos

Hector Francisco Valdovinos

Auto-generated profile, based on publicly available information

Hector Francisco Valdovinos

Medical Physics Department, University of Wisconsin-Madison, Madison, WI, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2013 in ACS Nano
Verified
Journal Article
Closed access
FCFeng Chen
Feng Chen
HHHao Hong
Hao Hong
YZYin Zhang
Yin Zhang
HVHector F. Valdovinos
Hector F. Valdovinos
SSSixiang Shi
Sixiang Shi
WCWeibo Cai
Weibo Cai

30 May 2014 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FCFeng Chen
Feng Chen
HHHao Hong
Hao Hong
SSSixiang Shi
Sixiang Shi
SGShreya Goel
Shreya Goel
HVHector F. Valdovinos
Hector F. Valdovinos
WCWeibo Cai
Weibo Cai
Hollow mesoporous silica nanoparticle (HMSN) has recently gained increasing interests due to their tremendous potential as an attractive nano-platform for cancer imaging and therapy. However, possibly due to the lack of efficient in vivo targeting strategy and well-developed surface engineering techniques, engineering of HMSN for in vivo active tumor targeting, quantitative tumor uptake assessment, multimodality imaging, biodistribution and enhanced drug delivery have not been achieved to date. Here, we report the in vivo tumor targeted positron emission tomography (PET)/near-infrared fluorescence (NIRF) dual-modality imaging and enhanced drug delivery of HMSN using a generally applicable surface engineering technique. Systematic in vitro and in vivo studies have been performed to investigate the stability, tumor targeting efficacy and specificity, biodistribution and drug delivery capability of well-functionalized HMSN nano-conjugates. The highest uptake of TRC105 (which binds to CD105 on tumor neovasculature) conjugated HMSN in the 4T1 murine breast cancer model was ~10%ID/g, 3 times higher than that of the non-targeted group, making surface engineered HMSN a highly attractive drug delivery nano-platform for future cancer theranostics.

18 April 2017 in Nano Letters
Verified
Journal Article
Closed access
DNDalong Ni
Dalong Ni
DJDawei Jiang
Dawei Jiang
HVHector F. Valdovinos
Hector F. Valdovinos
EEEmily B. Ehlerding
Emily B. Ehlerding
BYBo Yu
Bo Yu
WCWeibo Cai
Weibo Cai

22 September 2016 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
AKAnyanee Kamkaew
Anyanee Kamkaew
LCLiang Cheng
Liang Cheng
SGShreya Goel
Shreya Goel
HVHector F. Valdovinos
Hector F. Valdovinos
TBTodd E. Barnhart
Todd E. Barnhart
WCWeibo Cai
Weibo Cai

18 June 2014 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
RCRubel Chakravarty
Rubel Chakravarty
HVHector F. Valdovinos
Hector F. Valdovinos
FCFeng Chen
Feng Chen
CLChristina M. Lewis
Christina M. Lewis
PEPaul A. Ellison
Paul A. Ellison
WCWeibo Cai
Weibo Cai

1 May 2018 in Biomaterials
Verified
Journal Article
Closed access
CXCheng Xu
Cheng Xu
FCFeng Chen
Feng Chen
HVHector F. Valdovinos
Hector F. Valdovinos
DJDawei Jiang
Dawei Jiang
SGShreya Goel
Shreya Goel
WCWeibo Cai
Weibo Cai